Cerecor Inc (NASDAQ:CERC) VP James Archie Harrell, Jr. bought 4,398 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was purchased at an average cost of $2.85 per share, for a total transaction of $12,534.30. Following the transaction, the vice president now directly owns 8,554 shares of the company’s stock, valued at approximately $24,378.90. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
NASDAQ:CERC traded up $0.27 during trading hours on Tuesday, reaching $5.25. 164,102 shares of the company were exchanged, compared to its average volume of 80,720. Cerecor Inc has a 1-year low of $2.71 and a 1-year high of $7.65. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.95 and a quick ratio of 0.91.
Cerecor (NASDAQ:CERC) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.03. The business had revenue of $5.41 million for the quarter, compared to the consensus estimate of $4.85 million. Cerecor had a negative return on equity of 120.67% and a negative net margin of 226.50%. On average, equities analysts predict that Cerecor Inc will post -0.64 EPS for the current year.
A number of large investors have recently modified their holdings of CERC. Vanguard Group Inc lifted its position in shares of Cerecor by 10.1% in the 3rd quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after acquiring an additional 8,094 shares during the period. BlackRock Inc. lifted its position in shares of Cerecor by 18.5% in the 4th quarter. BlackRock Inc. now owns 33,960 shares of the company’s stock worth $109,000 after acquiring an additional 5,293 shares during the period. Northern Trust Corp lifted its position in shares of Cerecor by 47.9% in the 4th quarter. Northern Trust Corp now owns 20,079 shares of the company’s stock worth $65,000 after acquiring an additional 6,500 shares during the period. Geode Capital Management LLC lifted its position in shares of Cerecor by 50.7% in the 4th quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock worth $306,000 after acquiring an additional 31,951 shares during the period. Finally, Prosight Management LP bought a new position in shares of Cerecor during the 4th quarter worth approximately $994,000. 53.94% of the stock is currently owned by institutional investors and hedge funds.
Cerecor Company Profile
Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device.
Featured Article: Treasury Bonds
Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.